Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anti-SARS-CoV-2 monoclonal antibodies
- Development stage
- Preclinical
- Lead developer
- Enzolytics
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intravenous, Intramuscular, Subcutaneous, Inhalation
01
Overview
Enzolytics is developing a series of fully human monoclonal antibodies (mAbs) for the treatment of COVID-19. These antibodies are identified through AI-driven analysis of over one million SARS-CoV-2 isolates to target 19 highly conserved, "immutable" epitopes on the virus. This approach is intended to ensure broad-spectrum neutralization across various viral variants, including Alpha, Beta, Gamma, Delta, and Lambda. The program is currently in preclinical development in collaboration with the Texas A&M University Institute for Preclinical Studies, with manufacturing support provided by Samsung Biologics.
- Other names
- Anti-SARS-CoV-2 mAbsAnti-SARS-CoV2 mAbsAnti-SARS-CoV 2 mAbs
02
Targets
RBM (SARS-CoV-2 spike receptor-binding motif)
Beyond the preview
Go deeper on Anti-SARS-CoV-2 monoclonal antibodies.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anti-SARS-CoV-2 monoclonal antibodies.